ReviewHealth science reports2026
Pre-Eclampsia Among Pregnant Women in Ghana: A Systematic Review & Meta-Analysis of the Current Prevalence, Risk Factors, and Perinatal Outcomes.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Pre-eclampsia (PE) is a major hypertensive disorder during pregnancy, contributing significantly to maternal and perinatal mortality, especially in low- and middle-income countries. While primary studies on PE have been conducted in Ghana and meta-analyses exist for sub-Saharan Africa broadly, no review has synthesized Ghana-specific evidence to produce a pooled prevalence estimate. This study aimed to provide a comprehensive summary of the prevalence, risk factors, and outcomes associated with PE among pregnant women in Ghana. Methods: Following the PRISMA guidelines, we searched four databases. Studies published between January 2015 and July 2025 were eligible for inclusion. Fourteen studies were included in the final meta-analysis. Pooled prevalence was calculated using random-effects meta-analysis in R Studio, with heterogeneity evaluated via the Results: The pooled prevalence of PE was 14.52% (95% CI: 7.88-22.74). Regional prevalence was highest in the Greater Accra (18.32%, 95% CI: 4.10-39.39), followed by Ashanti (17.41%, 95% CI: 6.38-32.32) and Northern (16.43%, 95% CI: 0.65-46.48) regions. Commonly reported risk factors included advanced maternal age, primigravidity, previous cesarean section, placental malaria, and vitamin D deficiency. Notable outcomes were lower Apgar scores, cesarean deliveries, stillbirths, and postpartum depression. Conclusion: PE affects a significant proportion of pregnant women in Ghana, with a pooled prevalence of 14.52%, which varies across regions and clinical settings. This estimate is derived from highly heterogeneous studies and should be interpreted as an approximate indicator of burden rather than a precise national figure. The identified risk factors and outcomes highlight the urgent need for enhanced prenatal screening and tailored interventions to reduce the burden of PE in Ghana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.